GlassScriptPhysician profile
Ericka E Quezada York
NPI 1821415506
$1,130.33
in general payments reported to CMS, 2019-2025
13 companies · $478 in 2025
The $478 reported for 2025 was more than what 95% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $140 · 2023: $113 · 2024: $230 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $212.84 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $159.44 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $144.95 | 2024-2025 | |
| Evofem Biosciences, INC. | $132.26 | 2021-2025 | Solosec, Phexx, Phexxi |
| Mayne Pharma Commercial LLC | $96.44 | 2023-2025 | |
| Exeltis, USA INC. | $71.32 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $69.64 | 2022 | |
| Abbvie INC. | $67.83 | 2021 | |
| Sumitomo Pharma America, INC. | $49.83 | 2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $47.09 | 2021 | |
| Organon LLC | $36.73 | 2022-2023 | Nexplanon |
| Coopersurgical, INC. | $26.25 | 2023 | Paragard T 380a |
| Aspira Women'S Health INC | $15.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ericka Quezada York listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.